News: PIQ Proteomics International Laboratories Launches PromarkerD In Spain Under Deal With Patia..., page-20

Great find @Eqz & thanks for your number crunching.

I was thinking about George’s question about who will pay for testing in Spain & so did a bit of digging.

Spain has an excellent healthcare system with 95% of patients covered publicly including for dialysis & renal transplant.

The population with CKD is huge in Spain, affecting 1 in 7 adults, similar to the USA, so you can see why PromarkerD would be of great benefit to the Spanish healthcare system in early detection of the disease, as opposed to the massive healthcare costs in treating late stage kidney disease (dialysis & transplantation); some links here:

https://www.ncbi.nlm.nih.gov/m/pubmed/29914761/

https://www.ncbi.nlm.nih.gov/m/pubmed/21688247/

Still reading, as one of these articles was published in 2011 & there could have been some changes since then in Spanish health policy. Have a great day all.